No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 7.8x · 10Y median 7.2x · 63rd percentile · as of Oct 2, 2026
Annualized revenue (TTM) · by quarter, last 26
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-03T03:54:18.761Z. Latest historical point 2026-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-03T03:54:18.761Z. Latest historical point 2026-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-03T03:54:18.761Z. Latest historical point 2026-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-03T03:54:18.761Z. Latest historical point 2026-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-03T03:54:18.761Z. Latest historical point 2026-09-30.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-03T03:54:18.761Z. Latest historical point 2026-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-03T03:54:18.761Z. Latest historical point 2026-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-03T03:54:18.761Z. Latest historical point 2026-09-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Allegro MicroSystems, Inc. (ALGM) stock was $39.53 as of Oct 2, 2026, 4:00 PM EDT, up 8.66% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +39.2% · 3-year avg +7.4%/yr · 5-year avg +4.6%/yr
Allegro MicroSystems, Inc. focuses on the creation, production, and worldwide distribution of sophisticated integrated circuits (ICs).
Semiconductors · Manchester, NH
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-03-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Oct 29, 2026
26 days away
EPS Estimate
0.24
Revenue Est.
$270.81M
Last Quarter Results
EPS
$0.23
vs Estimate
$0.21
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1ALGM | $7.36B | $39.53 | +8.66% | +39.17% | +4.64% | N/A | N/A |
| 2SLAB | $7.35B | $222.76 | +0.11% | +66.88% | +9.68% | +14.24% | vs ALGM |
| 3PLXS | $7.31B | $273.13 | +1.06% | +85.60% | +24.55% | +19.29% | vs ALGM |
| 4APLD | $7.31B | $25.38 | +5.05% | -4.12% | N/A | N/A | vs ALGM |
| 5APPF | $7.25B | $202.97 | -0.62% | -19.74% | +10.02% | +26.42% | vs ALGM |
| 6CAMT | $7.71B | $165.19 | +7.41% | +40.61% | +32.68% | +50.35% | vs ALGM |
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$259.24M
vs Estimate
$251.44M
Consensus Rating
Based on 12 analysts
Average Price Target
$54.42
+37.7% upside
Low
$48.00
Current
$39.53
High
$62.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.24 | $0.25 | $0.25 | 7 |
| Quarter ending Dec 2026 | $0.24 | $0.26 | $0.28 | 6 |
| Quarter ending Mar 2027 | $0.28 | $0.29 | $0.30 | 2 |
| Quarter ending Jun 2027 | $0.31 | $0.32 | $0.33 | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $0.97 | $1.03 | $1.09 | 6 |
| FY 2028 | $1.39 | $1.50 | $1.65 | 6 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $269.68M | $270.89M | $272.09M | 5 |
| Quarter ending Dec 2026 | $272.69M | $276.68M | $280.68M | 5 |
| Quarter ending Mar 2027 | $281.47M | $290.09M | $295.66M | 2 |
| Quarter ending Jun 2027 | $293.34M | $302.32M | $308.12M | 2 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2027 | $1.06B | $1.10B | $1.11B | 7 |
| FY 2028 | $1.26B | $1.29B | $1.32B | 7 |
